1 September 2024

Audio Broadcast - BV Efficacy Trial Results

Melbourne Australia: Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) invites you to listen to an audio broadcast with Chief Executive Officer Dr Jackie Fairley, regarding the successful results of the major phase 2 clinical study that demonstrated efficacy of VivaGel® for the treatment of bacterial vaginosis (BV).

 

 The results of the trial were released to the ASX yesterday.

 

To listen to the Boardroom Radio audio broadcast please click on the following link, or copy and paste it into your browser:

 http://www.brr.com.au/event/81296

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.